Skip to main content
Medical Data Vision Co.,Ltd. logo

Medical Data Vision Co.,Ltd. — Investor Relations & Filings

Ticker · 3902 ISIN · JP3921250001 T Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 74 across all filing types
Latest filing 2025-02-14 Regulatory Filings
Country JP Japan
Listing T 3902

About Medical Data Vision Co.,Ltd.

https://en.mdv.co.jp/

Medical Data Vision Co., Ltd. (MDV) is a healthcare data provider that operates one of the largest medical databases in its market. The company aggregates and processes real-world administrative data from hundreds of hospitals, encompassing records for over 50 million patients. This database provides detailed insights into treatment patterns, patient conditions, and medication decision-making. MDV offers data and analytical services primarily to pharmaceutical companies, medical device manufacturers, and research institutions for use in research, development, and market analysis. Additionally, the company provides information and communication technology (ICT) solutions and management support systems for medical institutions.

Recent filings

Filing Released Lang Actions
臨時報告書
Regulatory Filings Classification · 100% confidence The document is titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and is submitted to the Kanto Local Finance Bureau Director (関東財務局長) on February 14, 2025. The filing reason explicitly states that an event significantly impacting the company's financial condition, operating results, and cash flow has occurred, citing Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act and related Cabinet Office Ordinance provisions. The content details financial adjustments, specifically investment losses from an equity-method affiliate (株式会社センシング) and goodwill impairment charges, affecting both individual and consolidated financial statements for the period ending December 2024. This structure—a formal, timely disclosure of a significant, non-periodic financial event—is characteristic of an extraordinary report in the Japanese regulatory context. Since there is no direct equivalent code for a Japanese 'Extraordinary Report' (like a US 8-K), and it is a formal regulatory filing detailing significant financial events that is not a standard periodic report (10-K, IR), the most appropriate fallback category is 'Regulatory Filings' (RNS). It is not an Earnings Release (ER) as it details specific impairment/loss events rather than broad quarterly results, nor is it a Call Transcript (CT) or Investor Presentation (IP). Given the nature of the disclosure, RNS is the best fit among the provided options for a general, significant regulatory disclosure.
2025-02-14 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 100% confidence The document title is "自己株券買付状況報告書（法24条の６第１項に基づくもの）" which translates to "Report on the Status of Treasury Stock Acquisition (Based on Article 24-6, Paragraph 1)". The document explicitly cites the legal basis as "金融商品取引法第24条の６第１項" (Financial Instruments and Exchange Act Article 24-6, Paragraph 1) and details the acquisition status of treasury stock (own shares) over a specific reporting period (January 1, 2025, to January 31, 2025). This type of filing specifically reports on the company's transactions involving its own shares, which directly corresponds to the definition of 'Transaction in Own Shares' (POS). It is not a general earnings release (ER), an annual report (10-K), or a management discussion (MDA).
2025-02-14 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 100% confidence The document title is "自己株券買付状況報告書（法24条の６第１項に基づくもの）" which translates to "Report on the Status of Acquisition of Own Shares (Based on Article 24-6, Paragraph 1 of the Act)". This explicitly details the company's activity regarding the repurchase of its own shares during a specific reporting period (December 1 to December 31, 2024). This directly corresponds to the definition of a Transaction in Own Shares (share repurchase/issuance), which is classified as code POS. The document is a formal report detailing the transaction status, not merely an announcement of a report's publication.
2025-01-07 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 100% confidence The document title is "自己株券買付状況報告書（法24条の６第１項に基づくもの）" which translates to 'Report on the Status of Treasury Stock Acquisition (Based on Article 24-6, Paragraph 1 of the Financial Instruments and Exchange Act)'. This document details the company's activities regarding the purchase of its own shares during a specific reporting period (November 1 to November 30, 2024). This directly corresponds to the definition of a report detailing the company buying back or selling its own shares, which is classified as 'Transaction in Own Shares' (POS). The document is a formal report, not an announcement of a report, and its content is highly specific to share repurchases.
2024-12-06 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares
2024-11-13 Japanese
自己株券買付状況報告書（法２４条の６第１項に基づくもの）
Transaction in Own Shares Classification · 100% confidence The document title is "自己株券買付状況報告書（法24条の６第１項に基づくもの）" which translates to 'Report on the Status of Treasury Stock Acquisition (Based on Article 24-6, Paragraph 1 of the Act)'. This document details the company's treasury stock acquisition activities during a specific reporting period (September 30, 2024). This specific regulatory filing in Japan concerns transactions involving the company's own shares (share repurchase/issuance). This directly matches the definition for 'Transaction in Own Shares' (POS).
2024-10-11 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.